Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK ; volume:36 ; number:7 ; day:25 ; month:5 ; year:2018 ; pages:867-878 ; date:7.2018
PharmacoEconomics ; 36, Heft 7 (25.5.2018), 867-878, 7.2018
- Creator
-
Buchanan, Vanessa
- Contributor
-
Sullivan, Will
Graham, Chris
Miles, LaStella
Jugl, Steffen Marc
Gunda, Praveen
Halliday, Anna
Kirkham, Bruce
SpringerLink (Online service)
- DOI
-
10.1007/s40273-018-0674-x
- URN
-
urn:nbn:de:101:1-2018082123140678882239
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Buchanan, Vanessa
- Sullivan, Will
- Graham, Chris
- Miles, LaStella
- Jugl, Steffen Marc
- Gunda, Praveen
- Halliday, Anna
- Kirkham, Bruce
- SpringerLink (Online service)
Other Objects (12)
Secukinumab: A Review in Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
Combination of secukinumab and natalizumab in the treatment of a patient with psoriatic arthritis and multiple sclerosis
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
Secukinumab: A Review in Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
Combination of secukinumab and natalizumab in the treatment of a patient with psoriatic arthritis and multiple sclerosis
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
Secukinumab: A Review in Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
Combination of secukinumab and natalizumab in the treatment of a patient with psoriatic arthritis and multiple sclerosis
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting